SAB Biotherapeutics (SABS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov15

SAB Biotherapeutics released FY2025 9 Months Earnings on November 14 (EST), Actual Revenue USD 0, Actual EPS USD -0.0228

04:00

SAB Biotherapeutics released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 83.33K), actual EPS USD -0.2126 (forecast USD -0.4583)

04:00

Oct22

Smith Analyst Covers Multiple Healthcare Stocks and Gives Strong Buy Rating to SAB Biotherapeutics

10:21

Oct18

Smith focuses on specific healthcare stocks

12:56

Aug8

SAB Biotherapeutics released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 0, actual EPS USD 0.1903

03:00

SAB Biotherapeutics released FY2025 Q2 earnings on August 7, 2025 (EST), actual revenue USD 0 (forecast USD 100K), actual EPS USD 0.749 (forecast USD -0.796)

03:00